Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HBV plus HCV, HCV plus HIV, HBV plus HIV.

Literature DB >> 16510037

HBV plus HCV, HCV plus HIV, HBV plus HIV.

James S Park¹, Neeraj Saraf, Douglas T Dieterich.

Abstract

Coinfection of hepatitis C virus (HCV), hepatitis B virus (HBV), and HIV is common due to shared modes of transmission. These coinfections accelerate the course of chronic liver disease and facilitate progression to cirrhosis and hepatocellular carcinoma. The viral interactions between these viruses are complex, and their treatment may be challenging for clinicians.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16510037 DOI： 10.1007/s11894-006-0066-9

Source DB: PubMed Journal: Curr Gastroenterol Rep ISSN： 1522-8037

61 in total

1. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals.

Authors: Lynn E Taylor; Theresa Costello; Elizabeth Alt; Gail Yates; Karen Tashima
Journal: AIDS Date: 2002-08-16 Impact factor: 4.177

Review 2. Care of patients with hepatitis C and HIV co-infection.

Authors: Vincent Soriano; Massimo Puoti; Mark Sulkowski; Stefan Mauss; Patrice Cacoub; Antonietta Cargnel; Douglas Dieterich; Angelos Hatzakis; Jurgen Rockstroh
Journal: AIDS Date: 2004-01-02 Impact factor: 4.177

3. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore.

Authors: Y M Wang; W C Ng; S K Lo
Journal: J Gastroenterol Date: 1999-08 Impact factor: 7.527

4. Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.

Authors: V Thibault; Y Benhamou; C Seguret; M Bochet; C Katlama; F Bricaire; P Opolon; T Poynard; H Agut
Journal: J Clin Microbiol Date: 1999-09 Impact factor: 5.948

5. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.

Authors: R P Woitas; J K Rockstroh; I Beier; G Jung; B Kochan; B Matz; H H Brackmann; T Sauerbruch; U Spengler
Journal: AIDS Date: 1999-07-30 Impact factor: 4.177

6. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

Authors: G K Lau; M Tsiang; J Hou; S Yuen; W F Carman; L Zhang; C S Gibbs; S Lam
Journal: Hepatology Date: 2000-08 Impact factor: 17.425

7. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors: Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal: J Hepatol Date: 2005-04-25 Impact factor: 25.083

8. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.

Authors: Scott E Kellerman; Debra L Hanson; A D McNaghten; Patricia L Fleming
Journal: J Infect Dis Date: 2003-08-05 Impact factor: 5.226

9. Dominant replication of either virus in dual infection with hepatitis viruses B and C.

Authors: K Koike; K Yasuda; H Yotsuyanagi; K Moriya; K Hino; K Kurokawa; S Iino
Journal: J Med Virol Date: 1995-02 Impact factor: 2.327

10. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Authors: Marion G Peters; H w Hann Hw; Paul Martin; E Jenny Heathcote; P Buggisch; R Rubin; M Bourliere; K Kowdley; C Trepo; D f Gray Df; M Sullivan; K Kleber; R Ebrahimi; S Xiong; Carol L Brosgart
Journal: Gastroenterology Date: 2004-01 Impact factor: 22.682

6 in total

1. Comparison of monolisa HCV Ag/Ab ULTRA with two anti-HCV assays for the detection of HCV infection in hospital setting.

Authors: Server Yagci; Elizaveta Padalko
Journal: Curr Microbiol Date: 2011-11-11 Impact factor: 2.188

Review 2. Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors: Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal: World J Gastroenterol Date: 2009-07-28 Impact factor: 5.742

3. Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome.

Authors: Sirish C Rao; Imran Ashraf; Fazia Mir; Sami Samiullah; Jamal A Ibdah; Veysel Tahan
Journal: Am J Case Rep Date: 2017-02-16

4. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients.

Authors: Giulia Morsica; Laura Galli; Emanuela Messina; Alessandro Cibarelli; Sabrina Bagaglio; Andrea Poli; Martina Ranzenigo; Antonella Castagna; Hamid Hasson; Caterina Uberti-Foppa
Journal: J Oncol Date: 2022-02-10 Impact factor: 4.375

Review 5. HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection.

Authors: Silvere D Zaongo; Jing Ouyang; Yaling Chen; Yan-Mei Jiao; Hao Wu; Yaokai Chen
Journal: Front Immunol Date: 2022-04-01 Impact factor: 8.786

6. Characterization of the Intestinal Fungal Microbiome in HIV and HCV Mono-Infected or Co-Infected Patients.

Authors: Yue Yin; Maermaer Tuohutaerbieke; Chengjie Feng; Xinjie Li; Yuqi Zhang; Qiang Xu; Jing Tu; Ence Yang; Qinghua Zou; Tao Shen
Journal: Viruses Date: 2022-08-18 Impact factor: 5.818

6 in total